Reagan-Udall reports mean different strokes for different arms of US FDA

The Reagan-Udall Foundation’s reports on the US Food and Drug Administration (FDA) provide “substantially different future policy implications” for the different FDA programs investigated, according to a lawyer specialising in FDA regulation.

The report on the FDA’s Human Foods Program emphasises specifics for the agency’s organisational structure – unlike the recommendations in the report on the FDA’s Center for Tobacco Products (CTP), which has a more operational focus, urging a more proactive approach to enforcement, attorney Joshua Ari Van De Riet told ECigIntelligence.